VivoSeq
Other

Total Intravenous Anesthesia

0

Pipeline Programs

10

Active Trials

0

Companies Involved

Total Intravenous Anesthesia is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

27/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

79/100

Attrition Rate

14/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

43

clinical trials

Completed23 · 53%
Recruiting7 · 16%
Unknown status4 · 9%
Not yet recruiting3 · 7%
Terminated3 · 7%
Withdrawn3 · 7%

Trial Activity

43 trials

Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)